MARKET

APYX

APYX

Apyx Medical Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.43
+0.34
+3.37%
Closed 16:11 06/18 EDT
OPEN
9.86
PREV CLOSE
10.09
HIGH
10.52
LOW
9.86
VOLUME
166.81K
TURNOVER
--
52 WEEK HIGH
12.01
52 WEEK LOW
4.350
MARKET CAP
357.94M
P/E (TTM)
-19.2969
1D
5D
1M
3M
1Y
5Y
Apyx Medical Corporation to Participate in the JMP Securities Life Sciences Conference
Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, anno...
Business Wire · 06/03 20:05
BRIEF-Apyx Medical Corporation Announces FDA 510(K) Submission For The Use Of Renuvion® In Dermal Resurfacing Procedures
reuters.com · 06/01 11:43
Apyx Medical Corporation Announces FDA 510(k) Submission For Use Of Renuvion In Dermal Resurfacing Procedures
Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery
Benzinga · 06/01 11:37
Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion® in Dermal Resurfacing Procedures
Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, toda...
Business Wire · 06/01 11:30
Apyx Medical Submits 510(k) Notification to FDA for Renuvion Use in Dermal Resurfacing
MT Newswires · 06/01 10:01
ROCE Insights For Apyx Medical
In Q1, Apyx Medical (NASDAQ:APYX) posted sales of $8.64 million. Earnings were up 151.59%, but Apyx Medical still reported an overall loss of $4.84 million. In Q4, Apyx Medical brought in $11.46 million in sales but lost $1.92 million in earnings.
Benzinga · 05/26 12:58
Apyx Medical Stock Gives Every Indication Of Being Modestly Overvalued
GuruFocus News · 05/16 04:05
10-Q: APYX MEDICAL CORP
(EDGAR Online via COMTEX) -- MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS ITEM 2. Management's Discussion and...
Edgar Online - (EDG = 10Q, 10K) · 05/12 18:16
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of APYX. Analyze the recent business situations of Apyx Medical Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average APYX stock price target is 12.50 with a high estimate of 14.00 and a low estimate of 12.00.
EPS
Institutional Holdings
Institutions: 110
Institutional Holdings: 21.51M
% Owned: 62.68%
Shares Outstanding: 34.32M
TypeInstitutionsShares
Increased
24
642.98K
New
7
352.93K
Decreased
25
363.51K
Sold Out
4
231.47K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.07%
Healthcare Equipment & Supplies
-0.86%
Key Executives
Chairman/Independent Director
Andrew Makrides
Chief Executive Officer/Director
Charles Goodwin
Vice Chairman/Independent Director
John Andres
Chief Financial Officer/Treasurer/Secretary
Tara Semb
Executive Vice President
Todd Hornsby
Senior Vice President
Moshe Citronowicz
Lead Director/Independent Director
Lawrence Waldman
Independent Director
Minnie Baylor-Henry
Independent Director
Michael Geraghty
Independent Director
Craig Swandal
No Data
About APYX
Apyx Medical Corporation, formerly Bovie Medical Corporation, is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It operates through two segments: OEM and J-Plasma. It is engaged in developing and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctor's offices, surgery centers and hospitals around the world. It also develops J-Plasma, a helium-based plasma surgical product. The J-Plasma system consists of an electrosurgical generator unit, a handpiece and a supply of helium gas. Its products are marketed through brands, including Aaron, DERM, IDS and ICON, and on a private label basis to distributors around the world. It offers products in electrosurgery, cauteries and other products categories.

Webull offers kinds of Apyx Medical Corp stock information, including NASDAQ:APYX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APYX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading APYX stock methods without spending real money on the virtual paper trading platform.